NSCLC without actionable oncogenic alterations


( Last Updated : June 23, 2022)
Project Status:
Pending
Therapeutic Area:
Unmutated Non-small cell lung cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0012-000

Details


Provisional Funding Algorithm

Draft Report Posted:

June 23, 2022

Stakeholder Feedback Deadline:

June 30, 2022

Final Report Posted (Target):

August 2, 2022

Call for feedback
Call for feedback:
Feedback Due By
Feedback Due By:
Consultation document
Consultation document: Draft Report
Product Line
Product Line: Reimbursement Review
Project Number
Project Number: PH0012-000